Lipophilic nalmefene prodrugs to achieve a one-month sustained release.

@article{Gaekens2016LipophilicNP,
  title={Lipophilic nalmefene prodrugs to achieve a one-month sustained release.},
  author={Tim Gaekens and M. Guillaume and H. Borghys and L. D. De Zwart and R. de Vries and R. Embrechts and A. Vermeulen and A. Megens and J. Leysen and P. Herdewijn and P. Annaert and J. Atack},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  year={2016},
  volume={232},
  pages={
          196-202
        }
}
  • Tim Gaekens, M. Guillaume, +9 authors J. Atack
  • Published 2016
  • Chemistry, Medicine
  • Journal of controlled release : official journal of the Controlled Release Society
Nalmefene is an opioid antagonist which as a once-a-day tablet formulation has recently been approved for reducing ethanol intake in alcoholic subjects. In order to address the compliance issue in this patient population, a number of potential nalmefene prodrugs were synthesized with the aim of providing a formulation that could provide plasma drug concentrations in the region of 0.5-1.0ng/mL for a one-month period when dosed intramuscular to dogs or minipigs. In an initial series of studies… Expand
Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy
Synthesis and evaluation of haloperidol ester prodrugs metabolically activated by human carboxylesterase
  • Masato Takahashi, T. Uehara, +4 authors M. Hosokawa
  • Chemistry, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2019
Insights on Fatty Acids in Lipophilic Prodrug Strategy
Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines.
Lipid-Drug Conjugate for Enhancing Drug Delivery.

References

SHOWING 1-10 OF 94 REFERENCES
Nalmefene: Intravenous safety and kinetics of a new opioid antagonist
Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
  • S. Kim, H. Wagner, +6 authors A. Civelek
  • Chemistry, Medicine
  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 1997
...
1
2
3
4
5
...